PCC Welcomes New Leadership to Board of Directors Toronto – April 2022 Pancreatic Cancer Canada (PCC) is excited to announce the election of Jonathan Paul to the role of Chair and Chris Andrews to the role of Vice-Chair of our Board of Directors. Both Mr....
Today I am thrilled to announce the launch of our next landmark research investment, PASS-01: a clinical trial that will finally address the diverse nature of this disease and provide personalized treatment options for advanced pancreatic cancer patients....
New Clinical Trial Studies Pancreatic Cancer Tumor Traits to Uncover Better Treatment Options NEW YORK – March 30, 2021 – A new team of pioneering pancreatic cancer researchers has been formed to predict which treatments might work best for...
Canadian Oncology Community Unites For World Cancer Day: Shedding Light on the Impact of Covid-19 on Cancer Care Oncologists estimate cancer diagnoses down 25 per cent in some areas as a result of COVID-19 Some oncologists are also reporting an increase in later...
PCC Board Chair Dr. Anish Kirpalani talks about awareness, research and his personal connection to pancreatic cancer: The Health and Wellness Show with Dr. Mike Wahl Pancreatic Cancer Canada Chair Dr. Anish Kirpalani speaks with Dr. Mike Wahl about pancreatic cancer...
Alex Trebek’s Death and the Need for Innovative Research: 900CHML Pancreatic Cancer Canada CEO Michelle Capobianco speaks with 900CHML host Scott Thompson about Alex Trebek’s passing to stage IV pancreatic cancer, the need for public awareness and...
Recent Comments